OPCH
HealthcareOption Care Health, Inc. · Medical - Care Facilities · $3B
What is Option Care Health, Inc.?
Option Care Health is the largest independent provider of home and alternate-site infusion services in the United States. The company connects patients with complex chronic and acute conditions to clinical therapies they can receive outside a hospital setting.
Option Care Health generates revenue by delivering intravenous and specialty drug therapies directly to patients at home or in alternate infusion suites. Referrals come primarily from hospitals, physicians, and payers who seek lower-cost care settings. The company manages the full care continuum — pharmacy dispensing, nursing visits, and clinical monitoring — for conditions ranging from immune deficiencies to bleeding disorders and high-risk pregnancies.
Founded in 1996 and headquartered in Bannockburn, Illinois, Option Care Health has grown into a national infusion network.
- Home infusion therapy for chronic and acute conditions
- Immunoglobulin and anti-infective treatment programs
- Parenteral and enteral nutrition support services
- Therapies for chronic inflammatory and neurological disorders
- High-risk pregnancy and oncology infusion services
Is OPCH a Good Stock to Buy?
UQS Score rates OPCH as Good overall, reflecting a balanced profile across its five analytical pillars.
The Risk pillar stands out as the clearest positive, suggesting the business carries a manageable financial and operational risk profile relative to healthcare sector peers. Valuation is rated Attractive, meaning the stock does not appear to be priced at a premium relative to its fundamentals — a meaningful consideration for value-oriented investors.
Quality, Moat, and Growth are each rated Neutral, indicating that competitive differentiation and earnings power are in line with — but not clearly ahead of — sector norms.
See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does OPCH pay dividends?
No — Option Care Health, Inc. does not currently pay a dividend.
Option Care Health does not currently pay a dividend. For a company operating in a capital-intensive services model, retaining cash to fund network expansion, technology infrastructure, and potential acquisitions is a common strategic choice. Income-focused investors should factor this into their broader portfolio planning.
When does OPCH report earnings?
Option Care Health reports earnings on a quarterly cadence, consistent with standard practice for US-listed equities.
The company's recent results have reflected the dynamics of a growing but competitive home infusion market, where referral volume and payer mix are key drivers of top-line performance. Operational efficiency and patient retention remain central themes in each reporting period.
For the most recent quarter's results and guidance, visit Option Care Health's investor relations page directly.
OPCH Price History
+52.9% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Option Care Health, Inc.?
Based on Option Care Health, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
OPCH Long-term Outlook
The fundamental outlook for Option Care Health is shaped by its Neutral Growth pillar and Good Risk rating. Growth is expected to track the broader shift of complex therapies out of hospital settings — a structural tailwind — though the pace of expansion may be tempered by reimbursement pressures and competitive dynamics. The Attractive Valuation label suggests the market may not be fully pricing in longer-term volume growth potential.
Growth drivers
- Ongoing shift of specialty infusion care from hospitals to lower-cost home settings
- Expanding patient populations with chronic inflammatory and neurological conditions
- Potential for network densification and referral partner growth
Key risks
- Reimbursement rate pressure from government and commercial payers
- Competitive intensity from health system-owned infusion programs
- Execution risk in scaling nursing and pharmacy operations nationally
OPCH vs Peers
Option Care Health operates in a broader post-acute and home health services landscape alongside several notable peers.
Chemed operates across hospice and plumbing services, giving it a more diversified revenue base than a pure-play infusion provider like OPCH.
Brookdale focuses on senior living communities rather than home-based infusion, serving a different segment of the post-acute care continuum.
Extendicare is a Canadian operator of long-term care and home health services, offering geographic and regulatory contrast to OPCH's US-only model.
Frequently Asked Questions
What does Option Care Health do?
Option Care Health provides home and alternate-site infusion therapy services across the United States. The company delivers specialty drugs and clinical nursing support to patients managing complex conditions — including immune deficiencies, chronic inflammatory diseases, bleeding disorders, and high-risk pregnancies — outside of a traditional hospital environment.
Does OPCH pay dividends?
No, Option Care Health does not currently pay a dividend. The company retains its cash flow to support network growth and operational investment. Investors seeking regular income should note this when evaluating OPCH as part of a broader portfolio.
When does OPCH report earnings?
Option Care Health follows a standard quarterly earnings schedule. Specific dates are announced in advance on the company's investor relations page, which is the most reliable source for upcoming reporting dates and conference call details.
Is OPCH a good stock to buy?
UQS Score rates OPCH as Good overall. Its most notable positives are a Good Risk rating and an Attractive Valuation label. Quality, Moat, and Growth are each Neutral. Whether that profile fits your investment goals depends on your own risk tolerance and time horizon — the full pillar breakdown is available to Pro members.
Is OPCH overvalued?
Based on the UQS Valuation pillar, OPCH is rated Attractive, suggesting the stock is not trading at an elevated premium relative to its fundamentals. This does not guarantee price appreciation, but it does indicate the market may not be fully pricing in the company's longer-term growth potential.
How does OPCH compare to its competitors?
Option Care Health is the largest independent home infusion provider in the US, which distinguishes it from more diversified peers like Chemed Corporation and senior-living-focused operators like Brookdale. Its pure-play focus on infusion services gives it operational depth in a specialized niche within the broader post-acute care market.
What is OPCH's market cap bracket?
Option Care Health is classified as a mid-cap company. This places it in a range that often balances growth potential with greater operational maturity than smaller-cap peers, though mid-cap stocks can still carry meaningful volatility.
Who founded Option Care Health?
Option Care Health traces its origins to 1996. Detailed founding history, including key executives involved in the company's early development, is publicly available through the company's official corporate history and SEC filings.
Is OPCH a long-term quality indicator?
As a long-term quality indicator, OPCH's Good UQS Score reflects a business with manageable risk and reasonable valuation, but Neutral ratings across Quality, Moat, and Growth suggest the company has not yet demonstrated the durable competitive advantages that typically define the highest-quality long-term holdings.
What is the main competitive advantage of Option Care Health?
Option Care Health's scale as the largest independent home infusion network in the US is its primary structural advantage. A broad geographic footprint, established payer relationships, and an integrated pharmacy-plus-nursing model create meaningful operational barriers for smaller entrants trying to replicate its reach.
What sector does OPCH belong to?
OPCH operates in the Healthcare sector, specifically within home health and specialty pharmacy services. It sits at the intersection of post-acute care and specialty drug distribution — a segment that benefits from long-term demographic and cost-containment trends in the US healthcare system.
Is OPCH a growth stock or value stock?
Based on its UQS pillar profile, OPCH leans toward value characteristics. The Valuation pillar is rated Attractive while Growth is Neutral, suggesting the stock may appeal more to investors looking for reasonable pricing than to those seeking high-velocity earnings expansion.
Unlock Full OPCH Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the complete five-pillar UQS Score breakdown
- ✓Access detailed financial metrics and trend data
- ✓Compare OPCH against sector peers side by side
- ✓Screen for similarly rated mid-cap healthcare stocks
- ✓Get the full analyst-style quality and risk assessment
Pro Analysis
OPCH — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | 56.1 | 46.5 | 43.0 | 45.1 | 70.9 | 94.1 | -0.2 |
| May 4, 2026 | 56.3 | 46.9 | 43.0 | 45.5 | 70.9 | 94.1 | -0.8 |
| May 3, 2026 | 57.1 | 46.9 | 43.0 | 49.2 | 70.9 | 94.1 | +1.5 |
| Apr 26, 2026 | 55.6 | 46.9 | 43.0 | 49.2 | 70.9 | 84.1 | +0.1 |
| Apr 19, 2026 | 55.5 | 46.9 | 43.0 | 49.2 | 70.9 | 83.6 | 0.0 |
| Apr 18, 2026 | 55.5 | 46.9 | 43.0 | 49.2 | 70.9 | 83.7 | -0.3 |
| Apr 12, 2026 | 55.8 | 46.9 | 43.0 | 49.2 | 70.9 | 85.4 | -0.3 |
| Apr 11, 2026 | 56.1 | 46.9 | 43.0 | 49.2 | 70.9 | 87.4 | +0.1 |
| Apr 9, 2026 | 56.0 | 46.6 | 43.0 | 49.2 | 70.9 | 87.4 | -0.1 |
| Apr 8, 2026 | 56.1 | 47.2 | 43.0 | 49.2 | 70.9 | 87.4 | -0.1 |
OPCH — Pillar Breakdown
Quality
— 50.1/100 (25%)Option Care Health, Inc. has average quality metrics, with room for improvement in margins or capital efficiency.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 43.6/100 (20%)Option Care Health, Inc. shows steady but unspectacular growth, typical for mature companies.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 75.2/100 (15%)Option Care Health, Inc. carries minimal financial risk with conservative leverage and strong solvency.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 94.5/100 (15%)Option Care Health, Inc. appears attractively valued relative to its earnings, cash flows, and sector peers.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 43/100 (25%)Option Care Health, Inc. possesses some competitive advantages but faces meaningful competition. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for OPCH.
Score Composition
Financial Data
More Stock Analysis
How is the OPCH UQS Score Calculated?
The UQS (Unified Quality Score) for Option Care Health, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Option Care Health, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Option Care Health, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.